by Vandana Singh | Jun 11, 2026 | General
Takeda Pharmaceutical Company Limited (NYSE:TAK) on Thursday shared topline results for the Phase 3 comparing zasocitinib (TAK-279) to Bristol-Myers Squibb Co.’s (NYSE:BMY) Sotyktu (deucravacitinib) in adults with moderate-to-severe plaque psoriasis (PsO)....
by Lekha Gupta | Jun 11, 2026 | General
Texxon Holding (NASDAQ:NPT) is trading lower by about half a percent on Thursday as traders fade the recent rebound and the stock continues to lag the broader risk-on tone. The Nasdaq is up 0.97% while the S&P 500 has gained 0.23%. What Is Driving NPT Stock Today?...
by Akanksha Bakshi | Jun 11, 2026 | General
The Lovesac Company (NASDAQ:LOVE) reported first-quarter fiscal 2027 results that topped analyst expectations, but stock fell after the furniture retailer narrowed its full-year sales and earnings outlook amid ongoing pressure on lower-priced purchases. First-Quarter...
by Evette Mitkov | Jun 11, 2026 | General
Virgin Galactic Holdings Inc. (NYSE:SPCE) shares are jumping as excitement around the upcoming SpaceX IPO reached new heights. Here’s what you should know. Virgin Galactic Holdings shares are climbing with conviction. What’s behind SPCE gains? SpaceX is preparing to...
by Benzinga Insights | Jun 11, 2026 | General
AutoZone (NYSE:AZO) has outperformed the market over the past 20 years by 9.87% on an annualized basis producing an average annual return of 19.12%. Currently, AutoZone has a market capitalization of $50.99 billion. Buying $1000 In AZO: If an investor had bought $1000...
by Vandana Singh | Jun 11, 2026 | General
Johnson & Johnson (NYSE:JNJ) on Thursday presented detailed results from its Phase 2/3 ENERGY study showing that IMAAVY (nipocalimab-aahu) achieved a statistically significant, durable hemoglobin response in patients with warm autoimmune hemolytic anemia (wAIHA)....
Recent Comments